Company Filing History:
Years Active: 2005
Title: Ralf Ladwig: Innovator in Bioadhesive Tablet Technology
Introduction
Ralf Ladwig is a notable inventor based in Jena, Germany. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of bioadhesive tablets. His innovative approach addresses the needs of elderly men suffering from partial androgen deficiency.
Latest Patents
Ralf Ladwig holds a patent for a bioadhesive tablet containing testosterone/testosterone ester mixtures. The patent describes a method for producing a predetermined testosterone time-release profile. This method involves spray-drying an alcoholic solution or suspension of testosterone and at least one testosterone ester, preferably in a ratio of 1:10 to 1:1.5, with an organic polymer. The resulting bioadhesive tablet is designed to control testosterone blood levels effectively.
Career Highlights
Throughout his career, Ralf Ladwig has worked with prominent companies in the pharmaceutical industry. He has been associated with Jenapharm GmbH & Co. KG and Bayer Pharma Aktiengesellschaft. His work has focused on developing innovative solutions that enhance the quality of life for patients.
Collaborations
Ralf Ladwig has collaborated with several professionals in his field, including Doris Huebler and Guenter Kaufmann. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Ralf Ladwig's contributions to the field of bioadhesive tablets represent a significant advancement in pharmaceutical technology. His innovative methods and collaborations have the potential to improve the management of testosterone levels in patients, particularly the elderly.